“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. 2023. World Bulletin of Public Health 18 (January): 9-14. https://scholarexpress.net/index.php/wbph/article/view/1965.